Related Experiment Video
Updated: Sep 16, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: November 1, 2010
The cost-effectiveness of HIV prevention targeting: how much more bang for the buck?
1Department of Epidemiology and Biostatistics, University of California, San Francisco, USA.
Background:
Although the targeting of human immunodeficiency virus (HIV) prevention to high-risk populations has been widely discussed, its benefits have not been quantified.
Methods:
This analysis of cost-effectiveness combines an HIV epidemic model, target population scenarios, and data on the cost and impact of prevention.
Results:
The number of HIV infections averted in 5 years with $1 million in annual prevention spending ranges from 164 in high-risk populations to 0.4 in very-low-risk populations. Fortyfold to two-hundredfold differences in prevention costs could equalize HIV infections averted.
Conclusions:
Targeting appears to provide substantial benefit and should be considered in allocation decisions about prevention.
Related Concept Videos
Retrovirus Life Cycles
Preventive Healthcare Services
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

